Ironwood Pharmaceuticals
IRWD • NASDAQ
Ironwood Pharmaceuticals is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Thomas A. McCourt, with a market cap of $663.6M.
Market Cap$663.6M
Employees267.0
CEOThomas A. McCourt
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 6, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Ironwood Pharmaceuticals FAQ
Common questions about Ironwood Pharmaceuticals
Ironwood Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 6, 2026 before market open. Analysts estimate revenue of $92.1M.
Ironwood Pharmaceuticals has approximately 267 employees.